Glucotrack Stock Price Prediction
| GCTK Stock | USD 0.25 0.01 3.85% |
Oversold Vs Overbought
21
Oversold | Overbought |
Using GlucoTrack hype-based prediction, you can estimate the value of GlucoTrack from the perspective of GlucoTrack response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in GlucoTrack to buy its stock at a price that has no basis in reality. In that case, they are not buying GlucoTrack because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
GlucoTrack after-hype prediction price | USD 0.17 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
GlucoTrack |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GlucoTrack's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
GlucoTrack After-Hype Price Prediction Density Analysis
As far as predicting the price of GlucoTrack at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in GlucoTrack or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of GlucoTrack, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
GlucoTrack Estimiated After-Hype Price Volatility
In the context of predicting GlucoTrack's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on GlucoTrack's historical news coverage. GlucoTrack's after-hype downside and upside margins for the prediction period are 0.01 and 12.17, respectively. We have considered GlucoTrack's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
GlucoTrack is out of control at this time. Analysis and calculation of next after-hype price of GlucoTrack is based on 3 months time horizon.
GlucoTrack Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as GlucoTrack is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading GlucoTrack backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with GlucoTrack, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.31 | 12.00 | 0.14 | 0.23 | 6 Events / Month | 6 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.25 | 0.17 | 30.21 |
|
GlucoTrack Hype Timeline
GlucoTrack is currently traded for 0.25. The entity has historical hype elasticity of -0.14, and average elasticity to hype of competition of 0.23. GlucoTrack is anticipated to decline in value after the next headline, with the price expected to drop to 0.17. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -30.21%, whereas the daily expected return is currently at -2.31%. The volatility of related hype on GlucoTrack is about 12272.73%, with the expected price after the next announcement by competition of 0.48. About 35.0% of the company shares are held by company insiders. The company recorded a loss per share of 2.91. GlucoTrack had not issued any dividends in recent years. The entity had 1:5 split on the 20th of May 2024. Given the investment horizon of 90 days the next anticipated press release will be in about 6 days. Check out GlucoTrack Basic Forecasting Models to cross-verify your projections.GlucoTrack Related Hype Analysis
Having access to credible news sources related to GlucoTrack's direct competition is more important than ever and may enhance your ability to predict GlucoTrack's future price movements. Getting to know how GlucoTrack's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how GlucoTrack may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RSLS | ReShape Lifesciences | 0.08 | 5 per month | 0.00 | (0.11) | 7.93 | (10.12) | 42.57 | |
| BBLG | Bone Biologics Corp | (0.13) | 2 per month | 8.81 | 0.04 | 18.13 | (17.14) | 163.17 | |
| TIVC | Tivic Health Systems | (0.01) | 7 per month | 0.00 | (0.03) | 12.12 | (6.90) | 79.31 | |
| NUWE | Nuwellis | 0.58 | 6 per month | 10.87 | 0.06 | 25.66 | (20.93) | 141.14 | |
| NAOV | NanoVibronix | (0.04) | 4 per month | 4.97 | 0.06 | 9.26 | (7.46) | 32.03 | |
| NXL | Nexalin Technology | 0.61 | 10 per month | 6.60 | 0.23 | 25.71 | (12.22) | 71.17 | |
| BJDX | Bluejay Diagnostics | (0.20) | 4 per month | 0.00 | (0.08) | 13.03 | (13.14) | 120.52 | |
| IRIX | IRIDEX | 0.02 | 9 per month | 0.00 | (0.03) | 4.76 | (5.33) | 40.39 | |
| HSDT | Helius Medical Technologies | (0.03) | 3 per month | 0.00 | (0.05) | 13.16 | (11.46) | 60.51 |
GlucoTrack Additional Predictive Modules
Most predictive techniques to examine GlucoTrack price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for GlucoTrack using various technical indicators. When you analyze GlucoTrack charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About GlucoTrack Predictive Indicators
The successful prediction of GlucoTrack stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as GlucoTrack, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of GlucoTrack based on analysis of GlucoTrack hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to GlucoTrack's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to GlucoTrack's related companies. | 2023 | 2024 (projected) | Dividend Yield | 1.05E-4 | 1.0E-4 | Price To Sales Ratio | 512.07 | 635.84 |
Story Coverage note for GlucoTrack
The number of cover stories for GlucoTrack depends on current market conditions and GlucoTrack's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that GlucoTrack is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about GlucoTrack's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
GlucoTrack Short Properties
GlucoTrack's future price predictability will typically decrease when GlucoTrack's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of GlucoTrack often depends not only on the future outlook of the potential GlucoTrack's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. GlucoTrack's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.2 M | |
| Cash And Short Term Investments | 4.5 M |
Check out GlucoTrack Basic Forecasting Models to cross-verify your projections. For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlucoTrack. If investors know GlucoTrack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlucoTrack listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.91) | Return On Assets (1.57) | Return On Equity (5.41) |
The market value of GlucoTrack is measured differently than its book value, which is the value of GlucoTrack that is recorded on the company's balance sheet. Investors also form their own opinion of GlucoTrack's value that differs from its market value or its book value, called intrinsic value, which is GlucoTrack's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlucoTrack's market value can be influenced by many factors that don't directly affect GlucoTrack's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlucoTrack's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlucoTrack is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlucoTrack's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.